POWCHIK PETERofficer: SVP Clinical Development & Regofficer: SVP Clinical Developme..
Common Stock
1,921
N/A
N/A
Option
VAN PLEW DANIEL Pofficer: EVP & General Mgr Industrial Oofficer: EVP & General Mgr Indu..
Common Stock
1,921
N/A
N/A
Option
YANCOPOULOS GEORGEdirector, officer: President and Chief ..director, officer: President an..
Common Stock
1,921
N/A
N/A
Option
YANCOPOULOS GEORGEdirector, officer: President and Chief ..director, officer: President an..
Incentive Stock Option (right to buy)
1,921
N/A
N/A
Option
POWCHIK PETERofficer: SVP Clinical Development & Regofficer: SVP Clinical Developme..
Incentive Stock Option (right to buy)
1,921
N/A
N/A
Option
MCCORKLE DOUGLAS Sofficer: VP Controller and Asst Treasurofficer: VP Controller and Asst..
Common Stock
1,921
N/A
N/A
Option
VAN PLEW DANIEL Pofficer: EVP & General Mgr Industrial Oofficer: EVP & General Mgr Indu..
Incentive Stock Option (right to buy)
1,921
N/A
N/A
Option
STAHL NEILofficer: EVP Research and Developmentofficer: EVP Research and Devel..
Common Stock
1,921
N/A
N/A
Option
MCCORKLE DOUGLAS Sofficer: VP Controller and Asst Treasurofficer: VP Controller and Asst..
Incentive Stock Option (right to buy)
1,921
N/A
N/A
Option
STAHL NEILofficer: EVP Research and Developmentofficer: EVP Research and Devel..
Incentive Stock Option (right to buy)
1,921
N/A
N/A
Sale
BROWN MICHAEL Sdirectordirector
Common Stock
3,000
N/A
N/A
Option
BROWN MICHAEL Sdirectordirector
Common Stock
3,000
N/A
N/A
Showing 1650 to 1700 of 2922 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.